子宫内膜异位症患者血浆hsa-miRNA-154-5p表达是该病潜在的诊断标志物
这项前瞻性队列研究分三阶段筛选、发现和验证血浆微小RNA(miRNA)标志物,比较51例子宫内膜异位症患者与41例对照。结果显示特定血浆miRNA特征与子宫内膜异位症相关,hsa-miR-154-5p单独或与hsa-miR-196b-5p、hsa-miR-378a-3p、hsa-miR-33a-5p及体重指数、年龄联合,可能用于该病无创诊断。
要点
- 特定血浆miRNA特征与子宫内膜异位症相关。
- hsa-miR-154-5p单独或联合其他miRNA及临床参数,可能用于无创诊断。
- 部分循环血浆miRNA表达水平在月经周期各阶段发生变化。
核心结论
- 血浆miRNA似乎是子宫内膜异位症无创诊断有前景的候选标志物。
- 其他临床参数可能有助于区分子宫内膜异位症女性与健康个体。
研究设计与样本
- 前瞻性队列研究,纳入51例子宫内膜异位症患者与41例对照。
- 研究分三阶段:标志物筛选、发现和验证。
- 用定量PCR芯片分析两组血浆miRNA表达差异,并以生物信息学建模和受试者工作特征曲线分析评估诊断性能。
主要发现
- 数据显示特定血浆miRNA特征与子宫内膜异位症相关。
- hsa-miR-154-5p单独或与hsa-miR-196b-5p、hsa-miR-378a-3p、hsa-miR-33a-5p及体重指数和年龄联合,可能适用于该病无创诊断。
- 部分循环血浆miRNA表达水平在月经周期各阶段发生变化。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
RESEARCH QUESTION: As microRNA (miRNA) are stable in circulation, this study tested whether they could serve as putative non-invasive biomarkers for endometriosis, and their expression differences between endometriosis patients and controls. It also addressed whether the combination of differently expressed miRNA together with clinical parameters in a statistical model could distinguish between endometriosis patients and controls. DESIGN: This prospective cohort study explored the possibility of using changes in extracellular miRNA spectra in plasma of 51 patients with endometriosis compared with 41 controls combined with clinical data as non-invasive biomarkers for the disease. The project was divided into three different phases for biomarker screening, discovery and validation. The differences in expression levels of plasma miRNA obtained from women with and without endometriosis were analysed with quantitative PCR-based microarrays. The diagnostic performance of the selected individual and/or combined differentially expressed miRNA candidates and clinical parameters was assessed using in silico bioinformatics modelling and receiver operating characteristic curve analysis. RESULTS: Data showed that a specific plasma miRNA signature is associated with endometriosis and that hsa-miR-154-5p, which alone or in combination with hsa-miR-196b-5p, hsa-miR-378a-3p, and hsa-miR-33a-5p and the clinical parameters of body mass index and age, are potentially applicable for non-invasive diagnosis of the disease. Changes in the levels of expression of certain circulating plasma miRNA also occurred within the phases of the menstrual cycle. CONCLUSIONS: miRNA seem to be promising candidates for the non-invasive diagnosis of endometriosis. Further, other clinical parameters may help in distinguishing women suffering from endometriosis from healthy individuals.
引用
- Pateisky P, Pils D, Szabo L, et al. hsa-miRNA-154-5p expression in plasma of endometriosis patients is a potential diagnostic marker for the disease. Reprod Biomed Online. 2018. PMID: 29857988. doi:10.1016/j.rbmo.2018.05.007
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。